169 related articles for article (PubMed ID: 38040526)
1. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors.
Wolf P; Maione L; Kamenický P; Chanson P
Arch Med Res; 2023 Dec; 54(8):102921. PubMed ID: 38040526
[TBL] [Abstract][Full Text] [Related]
2. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
3. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy.
Colao A; Baldelli R; Marzullo P; Ferretti E; Ferone D; Gargiulo P; Petretta M; Tamburrano G; Lombardi G; Liuzzi A
J Clin Endocrinol Metab; 2000 Jan; 85(1):193-9. PubMed ID: 10634386
[TBL] [Abstract][Full Text] [Related]
4. Acromegaly.
Scacchi M; Cavagnini F
Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone, acromegaly, and heart failure: an intricate triangulation.
Saccà L; Napoli R; Cittadini A
Clin Endocrinol (Oxf); 2003 Dec; 59(6):660-71. PubMed ID: 14974906
[TBL] [Abstract][Full Text] [Related]
6. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
7. [Acromegaly and it's cardiovascular implications].
Cadena-Obando DA; Remba-Shapiro I; Abreu-Rosario CG; Mercado M
Rev Med Inst Mex Seguro Soc; 2021 Feb; 59(1):73-80. PubMed ID: 33667046
[TBL] [Abstract][Full Text] [Related]
8. [Acromegalic cardiomyopathy].
Bencze A; Rácz K
Orv Hetil; 2011 Nov; 152(47):1875-8. PubMed ID: 22042313
[TBL] [Abstract][Full Text] [Related]
9. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
11. Cardiac and metabolic effects of chronic growth hormone and insulin-like growth factor I excess in young adults with pituitary gigantism.
Bondanelli M; Bonadonna S; Ambrosio MR; Doga M; Gola M; Onofri A; Zatelli MC; Giustina A; degli Uberti EC
Metabolism; 2005 Sep; 54(9):1174-80. PubMed ID: 16125529
[TBL] [Abstract][Full Text] [Related]
12. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly.
Lombardi G; Colao A; Marzullo P; Ferone D; Longobardi S; Esposito V; Merola B
J Endocrinol; 1997 Oct; 155 Suppl 1():S33-7; discussion S39. PubMed ID: 9389993
[TBL] [Abstract][Full Text] [Related]
15. Post-treatment heterogeneity of cardiometabolic risk in patients with acromegaly: The impact of GH and IGF-1.
Heydari M; Hashemi-Madani N; Emami Z; Khajavi A; Ghorbani M; Malek M; Ataei Kachuee M; Khamseh ME
Endocr Res; 2022 Feb; 47(1):1-7. PubMed ID: 34102938
[TBL] [Abstract][Full Text] [Related]
16. Role of growth hormone in chronic heart failure. Therapeutic implications.
Volterrani M; Manelli F; Cicoira M; Lorusso R; Giustina A
Drugs; 2000 Oct; 60(4):711-9. PubMed ID: 11085197
[TBL] [Abstract][Full Text] [Related]
17. [Cardiovascular disturbances in acromegaly].
Fedrizzi D; Czepielewski MA
Arq Bras Endocrinol Metabol; 2008 Dec; 52(9):1416-29. PubMed ID: 19197449
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular complications in acromegaly.
Vitale G; Pivonello R; Lombardi G; Colao A
Minerva Endocrinol; 2004 Sep; 29(3):77-88. PubMed ID: 15282442
[TBL] [Abstract][Full Text] [Related]
19. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
20. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]